Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase with EF-hand domain 1 is a member of the serine/threonine phosphatase family, containing at least two EF-hand calcium-binding motifs at its C-terminus. It is regulated by calmodulin and calcium ions, which activate the enzyme by relieving auto-inhibition mediated by an extended-IQ motif and EF-hand interaction. PPEF1 is implicated in apoptosis regulation—especially in cancer—by dephosphorylating PDCD5 and influencing p53 responses. It is highly conserved, shares sequence similarity with Drosophila’s retinal degeneration C gene, and is expressed in sensory neurons and testicular germ cells. Several splice variants exist, and dysfunction is associated with retinal degeneration, lymphoma, epilepsy, and tumorigenesis. As a calmodulin-binding protein integral to neuronal, visual, and reproductive functions, PPEF1 presents a potential therapeutic and diagnostic target in oncology and reproductive medicine.
Theoretically, inhibition of PPEF1 would increase apoptosis in cancer cells by stabilizing PDCD5 and stimulating p53-mediated apoptotic responses. No agents or validated inhibitors are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase with EF-hand domain 1 (PPEF1).